Skip to main content
 

Mediwhale

Mediwhale

Mediwhale is an innovative retina-based AI company that autonomously assesses cardiovascular disease risk. With a simple eye scan using fundus cameras, the company’s AI algorithm analyzes the blood vessels in the retinal images and generates a future cardiovascular disease risk with comparable performance to a heart CT scan within a minute, providing a safe, affordable, and accessible solution at the point of care. Mediwhale also expands the coverage from cardiovascular disease to renal and metabolic diseases.

More News

  • Smartphone apps, wearable trackers helped people with heart disease boost physical activity

  • Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

  • AccurKardia receives patent for AI-ECG cardiac amyloidosis detection